p53 immunostaining pattern in Brazilian patients with hepatocellular carcinoma

Revista do Instituto de Medicina Tropical de Sao Paulo

Volumn 46, Issue 1, 2004, Pages 25-31

  Alves, Venâncio Avancini Ferreira ^a   Nita, Marcelo Eidi ^b,c   Carrilho, Flair José ^a   Ono Nita, Suzane Kioko ^a   Wakamatsu, Alda ^a   Lehrbach, Dárcio Matenhauer ^b   De Carvalho, Maria Fernanda Pimentel ^b   De Mello, Evandro Sobroza ^a   Gayotto, Luiz Carlos Da Costa ^a   Da Silva, Luiz Caetano ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Discipline of Digest Tract Surgery   (Brazil)

^c São Paulo Univ Sch of Med ^*  (Brazil)

Author keywords

Apoptosis; Cell cycle; Hepatitis B; Hepatitis C; Immunohistochemistry; Liver cancer; p53

Indexed keywords

PROTEIN P53;

AFRICA; ARTICLE; BRAZIL; CHINA; CHRONIC LIVER DISEASE; ENVIRONMENTAL FACTOR; GENE EXPRESSION; GENE MUTATION; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HOST; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; TUMOR SUPPRESSOR GENE;

EID: 12144287252     PISSN: 00364665     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0036-46652004000100005     Document Type: Article

References (60)

1. AHSAN, H.; WANG, L.Y.; CHEN, C.J.; TSAI, W.Y. & SANTELLA, R.M. - Variability in aflatoxin-albumin adduct levels and effects of hepatitis B and C virus infection and glutathione S-transferase M1 and T1 genotype. Environ. Hlth. perspect., 109: 833-837, 2001.
2. ALTAF, F.J. - Hepatocellular carcinoma. Saudi Med. J., 22: 416-418, 2001.
3. ANTHONY, P.P.; VOGEL, C.L. & BARKER, L.F. - Liver cell dysplasia: a premalignant condition. J. Clin. Path., 26: 217-223, 1973.
4. ARAKAWA, M.; KAGE, M.; SUGIHARA, S. et al. - Emergence of malignant lesions within an adenomatous hyperplastic nodule in a cirrhotic liver. Observations in five cases. Gastroenterology, 91: 198-208, 1986.
5. BOIX-FERRERO, J.; PELLIN, A.; BLESA, R.; ADRADOS, M. & LLOMBART-BOSCH, A. - Absence of p53 gene mutations in hepatocarcinomas from a Mediterranean area of Spain. A study of 129 archival tumour samples. Virchows Arch., 434: 497-501, 1999.
6. BRESSAC, B.; KEW, M.; WANDS, J. & OZTURK, M. - Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature (Lond.), 350: 429-431, 1991.
7. BUENDIA, M.A. - Genetics of hepatocellular carcinoma. Semin. Cancer Biol., 10: 185-200, 2000.
8. CARRILHO, F.J. - Carcinoma hepatocelular e cirrose hepática. Estudo caso-controle de variáveis clínicas, bioquímicas, sorológicas e morfológicas. São Paulo, 1993. (Tese de Doutorado - Faculdade de Medicina da Universidade de São Paulo).
9. CARRILHO, F.J.; ALVES, V.A.F.; MELLO, E.S. & VEZOZZO, D.C.P. - Carcinoma hepatocelular. In: GAYOTTO, L.C.C. & ALVES, V.A. Doenças do fígado e das vias biliares. São Paulo, Atheneu, 2001. p. 997-1016.
10. CHALLEN, C.; LUNEC, J.; WARREN, W.; COLLIER, J. & BASSENDINE, M.F. - Analysis of the p53 tumor-suppressor gene in hepatocellular carcinomas from Britain. Hepatology, 16: 1362-1366, 1992.
11. CHEN, P.-J. & CHEN, D.-S. - Hepatitis B virus infection and hepatocellular carcinoma: molecular genetics and clinical perspectives. Semin. Liver Dis., 19: 253-262, 1999.
12. COURSAGET, P.; DEPRIL, N.; CHABAUD, M. et al. - High prevalence of mutations at codon 249 of the p53 gene in hepatocellular carcinomas from Senegal. Brit. J. Cancer, 67: 1395-1397, 1993.
13. DE BENEDETTI, V.M.; WELSH, J.A.; TRIVERS, G.E. et al. - p53 is not mutated in hepatocellular carcinomas from Alaska Natives. Cancer Epidem. Biomarkers Prev., 4: 79-82, 1995.
14. DENG, Z.; PAN, L. & MA, Y. - Sequence alterations in p53 gene of hepatocellular carcinoma from high aflatoxin risk area in Guangxi. Zhonghua Zhong Liu Za, Zhi., 19: 18-21, 1997.
15. DIAMANTS, I.D.; MCGANDY, C.; CHEN, T.J. et al. - A new mutational hot-spot in the p53 gene in human hepatocellular carcinoma. J. Hepatol., 20: 553-556, 1994.
16. DING, X.; PARK, Y.N.; TALTAVULL, T.C. et al. - Geographic characterization of hepatitis virus infections, genotyping of hepatitis B virus, and p53 mutation in hepatocellular carcinoma analyzed by in situ detection of viral genomes from carcinoma tissues: comparison among six different countries. Jap. J. infect. Dis., 56: 12-18, 2003.
17. DOMINGUES-MALAGON, H. & GAYTAN-GRAHAM, S. - Hepatocellular carcinoma: an update. Ultrastruct. Path., 25: 497-516, 2001.
18. DONATO, F.; BOFFETTA, P. & PUOTI, M. - A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma. Int. J. Cancer, 75: 347-354, 1998.
19. DOWELL, S.P. & HALL, P.A. - The p53 tumour suppressor gene and tumour prognosis: is there a relationship? J. Path., 177: 221-224, 1995.
20. EDAMOTO, Y.; HARA, A.; BIERNAT, W. et al. - Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis. Int. J. Cancer, 106: 334-341, 2003.
21. FISHER, C.J.; GILLETT, C.E.; VOJTESEK, B.; BARNES, D.M. & MILLIS, R.R. - Problems with p53 immunohistochemical staining: the effect of fixation and variation in the methods of evaluation. Brit. J. Cancer, 69: 26-31, 1994.
22. FU, Y.; DENG, W.; KAWARADA, Y. et al. - Mutation and expression of the p53 gene during chemical hepatocarcinogenesis in F344 rats. Biochim. Biophys. Acta, 1628: 40-49, 2003.
23. FUJIMOTO, Y.; HAMPTON, L.L.; WIRTH, P.J. et al. - Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China. Cancer Res., 54: 281-285, 1994.
24. HAYASHI, H.; SUGIO, K.; MATSUMATA, T. et al. - The clinical significance of p53 gene mutation in hepatocellular carcinomas from Japan. Hepatology, 22: 1702-1707, 1995.
25. HOLLSTEIN, M.C.; WILD, C.P.; BLEICHER, F. et al. - p53 mutations and aflatoxin B1 exposure in hepatocellular carcinoma patients from Thailand. Int. J. Cancer, 53: 51-55, 1993.
26. HONDA, K.; SBISA, E.; TULLO, A. et al. - p53 mutation is a poor prognostic indicator for survival in patients with hepatocellular carcinoma undergoing surgical tumour ablation. Brit. J. Cancer, 77: 776-782, 1998.
27. HSU, I.C.; METCALF, R.A.; SUN, T. et al. - Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature (Lond.), 350: 427-428, 1991.
28. HU, T.H.; HUANG, C.C.; LIN, P.R. et al. - Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma. Cancer, 97: 1929-1940, 2003.
29. HUANG, X.H.; SUN, L.H.; LU, D.D. et al. - Codon 249 mutation in exon 7 of p53 gene in plasma DNA: maybe a new early diagnostic marker of hepatocellular carcinoma in Qidong risk area, China. Wld. J. Gastroent., 9: 692-695, 2003.
30. HUO, T.I.; WANG, X.W.; FORGUES, M. et al. - Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis. Oncogene, 20: 3620-3628, 2001.
31. HUSSAIN, S.P. & HARRIS, C.C. - Molecular epidemiology and carcinogenesis: endogenous and exogenous carcinogens. Mutation Res., 462: 311-322, 2000.
32. JIANG, W.; LU, Q. & PAN, G. - p53 gene mutation in hepatocellular carcinoma. Zhonghua Wai Ke. Za. Zhi., 36: 531-532, 1998.
33. KAZACHKOV, Y.; KHAOUSTOV, V.; YOFFE, B. et al. - p53 abnormalities in hepatocellular carcinoma from United States patients: analysis of all 11 exons. Carcinogenesis, 17: 2207-2212, 1996.
34. KOJIRO, M. & NAKASHIMA, T. - Pathology of hepatocellular carcinoma. In: OKUDA, K. & ISHAK, K.G. Neoplasms of the liver. Tokyo, Springer-Verlag, 1987. p. 81-104.
35. KONDO, F.; WADA, K. & KONDO, Y. - Morphometric analysis of hepatocellular carcinoma. Virchows Arch. A Path. Anat. Histopath., 413: 425-430, 1988.
36. KRESS, S.; JAHN, U.R.; BUCHMANN, A.; BANNASCH, P. & SCHWARZ, M. - p53 mutations in human hepatocellular carcinomas from Germany. Cancer Res., 52: 3220-3223, 1992.
37. LAURENT-PUIG, P.; FLEJOU, J.F.; FABRE, M. et al. - Overexpression of p53: a rare event in a large series of white patients with hepatocellular carcinoma. Hepatology, 16: 1171-1175, 1992.
38. LIBBRECHT, L.; CRANINX, M.; NEVENS, F.; DESMET, V. & ROSKAMS, T. -Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with non-cirrhotic and cirrhotic chronic viral hepatitis. HistopathoIogy, 39: 66-73, 2001.
39. MELLO, E.S. - Macronódulos em fígados cirróticos: estudo morfológico com ênfase nos aspectos macroscópicos, proliferação e apoptose. São Paulo, 2001. (Tese de Doutorado - Faculdade de Medicina da Universidade de São Paulo).
40. MURAKAMI, Y.; HAYASHI, K.; HIROHASHI, S. & SEKIYA, T. - Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res., 51: 5520-5525, 1991.
41. NAKAMURA, T.; IWAMURA, Y.; KANEKO, M. et al. - Deletions and rearrangements of the retinoblastoma gene in hepatocellular carcinoma, insulinoma and some neurogenic tumors as found in a study of 121 tumors. Jap. J. clin. Oncol., 21: 325-329, 1991.
42. NG, I.O.; SRIVASTAVA, G.; CHUNG, L.P.; TSANG, S.W. & NG, M.M. - Overexpression and point mutations of p53 tumor suppressor gene in hepatocellular carcinomas in Hong Kong Chinese people. Cancer, 74: 30-37, 1994.
43. NISHIDA, N.; FUKUDA, Y.; KOKURYU, H. et al. - Accumulation of allelic loss on arms of chromosomes 13q, 16q and 17p in the advanced stages of human hepatocellular carcinoma. Int. J. Cancer, 51: 862-868, 1992.
44. NITA, M.E.; ALVES, V.A.F.; CARRILHO, F.J. et al. - Molecular aspects of hepatic carcinogenesis. Rev. Inst. Med. trop. S. Paulo, 44: 39-48, 2002.
45. NITA, M.E.; NAGAWA, H.; TOMINAGA, O. et al. - p21Waf1/Cip1 expression is a prognostic marker in curatively resected esophageal squamous cell carcinoma, but not p27Kip1, p53, or Rb. Ann. surg. Oncol., 6: 481-488, 1999.
46. ODA, T.; TSUDA, H.; SCARPA, A.; SAKAMOTO, M. & HIROHASHI, S. - p53 gene mutation spectrum in hepatocellular carcinoma. Cancer Res., 52: 6358-6364, 1992.
47. OH, S.H.; YAN, K.J.; NAN. J.X.; SOHN, D.H. & LEE, B.H. - Changes in expression and immunolocalization of protein associated with toxic bile salts-induced apoptosis in rat hepatocytes. Arch. Toxicol., 77: 110-115, 2003.
48. OHTA, G. & NAKANUMA, Y. - Comparative study of three nodular lesions in cirrhosis: adenomatoid hyperplasia, adenomatoid hyperplasia with intermediate lesion and small hepatocellular carcinoma. In: OKUDA, K. & ISHAK, K.G. Neoplasms of the liver. Tokyo, Springer-Verlag, 1987. p. 177-187.
49. OKUDA, K. - Hepatocellular carcinoma. J. Hepat., 32: 225-237, 2000.
50. OZTURK, M. - Genetic aspects of hepatocellular carcinogenesis. Semin. Liver Dis., 19: 235-242, 1999.
51. PAIVA, C.; OSHIMA, C.T.; LANZONI, V.P. & FORONES, N.M. - Apoptosis, PCNA and p53 in hepatocellular carcinoma. Hepatogastroenterology, 49: 1058-1061, 2002.
52. SCORSONE, K.A.; ZHOU, Y.Z.; BUTEL J.S. & SLAGLE, B.L. - p53 mutations cluster at codon 249 in hepatitis B virus-positive hepatocellular carcinomas from China. Cancer Res., 52: 1635-1638, 1992.
53. TANNAPFEL, A. & WITTEKIND, C. - Genes involved in hepatocellular carcinoma: deregulation in cell cycling and apoptosis. Virchows Arch., 440: 345-352, 2002.
54. TERAMOTO, T.; SATONAKA, K.; KITAZAWA, S. et al. - p53 gene abnormalities are closely related to hepatoviral infections and occur at a late stage of hepatocarcinogenesis. Cancer Res., 54: 231-235, 1994.
55. VESEY, D.A.; HAYWARD, N.K. & COOKSLEY, W.G. - p53 gene in hepatocellular carcinomas from Australia. Cancer Detect. Prev., 18: 123-130, 1994.
56. WONG, N.; LAI, P.; PANG, E. et al. - Genomic aberrations in human hepatocellular carcinomas of differing etiologies. Clin. Cancer Res., 6: 4000-4009, 2000.
57. WYNFORD-THOMAS, D. - p53 in tumour pathology: can we trust immunocytochemistry? J. Path., 166: 329-330, 1992.
58. ZERBINI, M.C.; SREDNI, S.T.; GRIER, H. et al. - Primary malignant epithelial tumors of the liver in children: a study of DNA content and oncogene expression. Pediat. Dev. Path., 1: 270-280, 1998.
59. ZHAO, M.; ZHANG, N.X.; LAISSUE, J.A. & ZIMMERMANN, A. -Immunohistochemical analysis of p53 protein overexpression in liver cell dysplasia and in hepatocellular carcinoma. Virchows Arch., 424: 613-621, 1994.
60. ZHOU, F.; WANG, J.; LEI, B. et al. - Detection of p53 gene mutations in hepatocellular carcinomas. Hua Xi Yi Ke Da Xue Xue, 28: 50-54, 1997.